Search for content, post, videos

Category

Contract Services

Recipharm-Research-Triangle-Park
0 COMMENT
62 Views
Recipharm opens new GMP suite

Recipharm has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USA. The suite, which represents a $750k investment, is intended to produce CTM for clinical studies up to Phase II for non-sterile dosage forms, including metered dose…

recipharm
0 COMMENT
185 Views
Recipharm manufactures to the Japanese market

Recipharm has entered into a long term agreement with Sato Pharmaceutical for the commercial manufacture and delivery of Emla Patch to Japan. Emla Patch is used as a local anaesthetic product and will be launched under the business area of ethical pharmaceuticals at Sato. Recipharm’s facility in Karlskoga, Sweden will…

recipharm
0 COMMENT
213 Views
Recipharm’s latest investment

Twenty years after its founding, Recipharm has established itself as a global life science firm with a solid base in its home country, Sweden and has become an example of a successful Nordic CDMO company. The firm is now setting out to strengthen its Swedish operations further with a new…

cmo
0 COMMENT
221 Views
Surviving as a CMO

What are the key factors for survival as a CMO today? We have spoken to some Nordic CMOs to get an insight into the current possibilities and challenges. The pharmaceutical sector is undergoing some dramatic changes, with pipeline challenges, pricing pressures and emerging global markets reshaping the way that companies…

polypeptide
0 COMMENT
145 Views
PolyPeptide completes acquisition of Lonza’s peptides business

The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l’Alleud, Belgium has been completed. The Braine facility, with approximately 280 employees, was the center for peptide chemical development and manufacturing within Lonza. The acquisition will enhance PolyPeptide’s manufacturing capacity and capabilities and will…

cmc-biologics
0 COMMENT
124 Views
AGC Asahi Glass acquires CMC Biologics

Danish CDMO CMC Biologics and AGC Asahi Glass (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, have entered into a definitive agreement with CMC Biologics’ shareholders including Monitor Clipper Partners, European Equity Partners and Innoven Partenaires, by which AGC will acquire 100% of CMC Biologics’ shares. “With the…

recipharm
0 COMMENT
84 Views
Recipharm enters new collaboration

Recipharm is entering into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure Pessary. The new product, which has been developed to help women suffering from bacterial vaginosis, will be manufactured, packaged and distributed globally from Recipharm’s facility in Karlskoga that specialises in the production of…

inficure
0 COMMENT
30 Views
InfiCure attracts international attention

The fibrosis model offered by Umeå based company InfiCure is attracting international attention and last month the startup signed their first contract for a full-service preclinical pilot study to test two substances for an american client in Boston. The trial i currently underway, with all lab work beeing done on…

recipharm
0 COMMENT
75 Views
Recipharm invests in its Italian API facility

Recipharm has announced an investment of over €1.2 million to enhance its small scale GMP active pharmaceutical ingredient (API) development and manufacturing capabilities in Paderno Dugnano, Italy. The investment, which is in response to growing demand for Recipharm’s custom synthesis and early phase API manufacturing capabilities, has seen the opening…

uppsala
0 COMMENT
94 Views
Recipharm to open new GLP bioanalysis laboratory in Uppsala

Recipharm has announced a 5 million SEK investment into a new GLP (Good Laboratory Practice) compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response to growing customer demand. The investment will see the opening of a 500 square metre purpose-built facility in November 2016, which will become the…

money sek
0 COMMENT
43 Views
Immuneed secures SEK 4.3M in financing

Immuneed secures SEK 4.3M in seed financing to further develop its immuno-oncology cancer vaccine candidate and grow its human whole-blood loop service for detection of acute immune related side effects of biopharmaceuticals. After Immuneed’s establishment in 2014 and early funding from Bio-X (Uppsala Bio/VINNOVA) and the Dutch Technology Foundation STW,…

Thomas-Eldered-Recipharm
0 COMMENT
74 Views
Recipharm creates global CDMO through new acquisitions

Swedish CDMO Recipharm continues to expand. Most recently the company acquired Kemwell’s pharmaceutical CDMO businesses. In February Recipharm acquired privately owned Italian CDMO Mitim, adding important technology in the filling of injectable beta lactams with sales to the US and European markets. The transaction is valued at an enterprise value…

Thomas-Eldered-Recipharm
0 COMMENT
79 Views
Recipharm to acquire Mitim Srl for SEK 640 million

Recipharm AB announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialised in the filling of injectable beta lactam products. It is located in Brescia close to Recipharm’s existing operations in…

recipharm
0 COMMENT
65 Views
Recipharm makes €40m investment

Recipharm will invest €40m over the next three years to ensure state of-the-art solutions for serialisation processes. The move by the company comes as the announcement of the EU Falsified Medicines Directive (EUFMD) Safety Features Delegated Regulation is released. This means that the serialisation of licensed drug products will be a legal requirement…

curida
0 COMMENT
76 Views
Curida signs agreement with Serviceproduksjon

Norwegian CDMO Curida has signed a framework-agreement with Serviceproduksjon, a subsidary to the Norwegian Pharmace Association. The agreement entails validation of a chemical analytical method for use in analysis of tablets and routine analysis of the particular drug. “Serviceproduksjon received offers from three other contract laboratories and chose Curida based…